[HTML] frontiersin.org

[HTML][HTML] Anti-CMV therapy, what next? A systematic review

C Gourin, S Alain, S Hantz - Frontiers in Microbiology, 2023 - frontiersin.org
Human cytomegalovirus (HCMV) is one of the main causes of serious complications in
immunocompromised patients and after congenital infection. There are currently drugs …
被引用次数：3 相关文章

Anti-CMV therapy, what next? A systematic review

C Gourin, S Alain, S Hantz - Frontiers in Microbiology, 2023 - europepmc.org
Human cytomegalovirus (HCMV) is one of the main causes of serious complications in
immunocompromised patients and after congenital infection. There are currently drugs …
[HTML] frontiersin.org

[HTML][HTML] Anti-CMV therapy, what next? A systematic review

C Gourin, S Alain, S Hantz - Frontiers in Microbiology, 2023 - frontiersin.org
Human cytomegalovirus (HCMV) is one of the main causes of serious complications in
immunocompromised patients and after congenital infection. There are currently drugs …
[HTML] nih.gov

[HTML][HTML] Anti-CMV therapy, what next? A systematic review

C Gourin, S Alain, S Hantz - Frontiers in Microbiology, 2023 - ncbi.nlm.nih.gov
Human cytomegalovirus (HCMV) is one of the main causes of serious complications in
immunocompromised patients and after congenital infection. There are currently drugs …

Anti-CMV therapy, what next? A systematic review

C Gourin, S Alain, S Hantz - Frontiers in microbiology, 2023 - pubmed.ncbi.nlm.nih.gov
Human cytomegalovirus (HCMV) is one of the main causes of serious complications in
immunocompromised patients and after congenital infection. There are currently drugs …